Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC150776 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KANSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF420 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKHD1-EIF4EBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PIN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKLE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZMYM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRCH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AATF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD19P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UPF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF3C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGTA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIPEP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on